Companies › DBVT

DBV TECHNOLOGIES S A (DBVT)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001613780 · EDGAR filings · Updated 2026-07-27

DBV TECHNOLOGIES S A (DBVT) has reported institutional ownership of 7.2%, with 71 institutional managers holding positions valued at $433.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-27 — S-3ASR filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-07-16 — Current report (8-K) filed
• 2026-07-16 — Quarterly report (10-Q) filed
• 2026-06-29 — Current report (8-K) filed
• 2026-06-05 — Current report (8-K) filed
• 2026-06-04 — Employee-plan registration (S-8) filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, DBV TECHNOLOGIES S A has 71 institutional holders and institutional ownership of 7.2%.

Insider activity

Insiders reported 11 transactions (0 buys, 8 sells) across 6 reporting insiders, with a net reported value of −$15.5M.

Data flags from SEC filings

Related companies

ETON PHARMACEUTICALS INC (ETON) · ANGIODYNAMICS INC (ANGO) · ABCELLERA BIOLOGICS INC (ABCL) · VERASTEM INC (VSTM) · RIGEL PHARMACEUTICALS INC (RIGL) · TECTONIC THERAPEUTIC INC (TECX)